New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Synta Pharmaceuticals Corp (NASDAQ:SNTA), AllianceBernstein Income Fund Inc (NYSE:ACG), Apollo Investment Corp (NASDAQ:AINV), DARA Biosciences Inc (NASDAQ:DARA)
Synta Pharmaceuticals Corp (NASDAQ:SNTA) showed a volume of 3.05 million shares by the end of last trade whereas the average volume of the stock remained 4.92 million shares. The stock opened the session at $0.25 but then moved to $0.276. At that price, the stock showed a positive performance of 0.32%. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases.
Will SNTA Continue To Move Higher? Find Out Here
AllianceBernstein Income Fund Inc (NYSE:ACG) opened the session at $7.49 and closed the session at $7.52. The stock showed a positive performance of 0.27% in previous trading session. Traded with volume of 1.49 million shares in the prior session and the average volume of the stock remained 1.38 million shares. AllianceBernstein Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund is designed to provide current income consistent with the preservation of capital. The Fund normally invests at least 80% of its net assets in income-producing securities.
For How Long ACG will fight for Profitability? Read This Trend Analysis report
Apollo Investment Corp (NASDAQ:AINV) opened the session at $8.87 and closed the session at $8.92. Traded with volume of 1.48 million shares in the prior session and the average volume of the stock remained 1.47 million shares. The beta of the stock remained 1.77. Apollo Investment Corporation (Apollo Investment) is a closed-end, non-diversified management investment company that has elected to be treated as a business development company. Its investment objective is to generate current income and capital appreciation.
Is AINV a Solid Investment at These Levels? Read This Report For Details
DARA Biosciences Inc (NASDAQ:DARA) the stock advanced 5.37% and finished the session at $0.760. Traded with volume of 1.45 million shares in the prior session and the average volume of the stock remained 1.61 million shares. The beta of the stock remained 1.50. DARA BioSciences, Inc. is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. The Company has the exclusive United States marketing rights to its Soltamox (oral liquid tamoxifen).
Will DARA Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)